Join
Live feed
·
PRReleasevia Quantisnow
ContextLogic Inc. logo

LogicBio Therapeutics Provides Update on LB-001 Clinical Development Program

ByQuantisnow·Wall Street's wire, on your screen.
LOGC· ContextLogic Inc.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LOGC (ContextLogic Inc.) and more on Quantisnow.